Clinical Trial Update: An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium [Phase 4]

View source ↗

Summary

The document reports the completion of a Phase 4 open-label exploratory trial evaluating gastric acid control in critically ill patients treated with Nexium (es…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Ulcer | Phase 4 | Status: COMPLETED